表紙
市場調查報告書
商品編碼
1028862

抗體藥物複合體 (ADC)的全球市場 (2021年) - COVID-19造成的成長和變化 (2030年)

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球抗體藥物複合體 (ADC) 市場相關調查分析,提供市場特徵,市場規模與成長率,市場區隔,各地區·各國明細,競爭情形,市場佔有率,趨勢與策略相關的系統性資訊。

目錄

第1章 摘要整理

第2章 抗體藥物複合體 (ADC) 市場特徵

第3章 抗體藥物複合體 (ADC) 市場趨勢與策略

第4章 抗體藥物複合體 (ADC) 市場上COVID-19的影響

第5章 抗體藥物複合體 (ADC)的市場規模與成長率

  • 全球抗體藥物複合體 (ADC) 市場實際成果 (金額)
  • 全球抗體藥物複合體 (ADC) 市場預測 (金額)

第6章 抗體藥物複合體 (ADC) 市場區隔

  • 全球抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 單株抗體
  • 連接試劑
  • 藥物/毒素
  • 其他
  • 全球抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 血液癌症
  • 乳癌
  • 卵巢癌症
  • 肺癌症
  • 腦瘤
  • 其他
  • 全球抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)
  • Adcertis
  • Kadcyla
  • 其他
  • 全球抗體藥物複合體 (ADC) 市場:各技術,實際成果與預測 (金額)
  • 免疫原技術
  • Seattle Genetics技術
  • Immunomedics技術
  • 其他
  • 全球抗體藥物複合體 (ADC) 市場:各終端用戶,實際成果與預測 (金額)
  • 醫院
  • 診所
  • 其他

第7章 抗體藥物複合體 (ADC) 市場各地區·各國分析

  • 全球抗體藥物複合體 (ADC) 市場:各地區,實際成果與預測 (金額)
  • 全球抗體藥物複合體 (ADC) 市場:各國,實際成果與預測 (金額)

第8章 亞太地區的抗體藥物複合體 (ADC) 市場

  • 亞太地區的抗體藥物複合體 (ADC) 市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,課稅,公司稅結構,投資,主要企業
  • 亞太地區的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 亞太地區的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 亞太地區的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第9章 中國的抗體藥物複合體 (ADC) 市場

  • 中國的抗體藥物複合體 (ADC) 市場概要
  • 中國的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 中國的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 中國的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第10章 印度的抗體藥物複合體 (ADC) 市場

  • 印度的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 印度的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 印度的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第11章 日本的抗體藥物複合體 (ADC) 市場

  • 日本的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 日本的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 日本的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第12章 澳洲的抗體藥物複合體 (ADC) 市場

  • 澳洲的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 澳洲的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 澳洲的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第13章 印尼的抗體藥物複合體 (ADC) 市場

  • 印尼的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 印尼的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 印尼的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第14章 韓國的抗體藥物複合體 (ADC) 市場

  • 韓國的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 韓國的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 韓國的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第15章 西歐的抗體藥物複合體 (ADC) 市場

  • 西歐的抗體藥物複合體 (ADC) 市場概要
  • 西歐的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 西歐的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 西歐的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第16章 英國的抗體藥物複合體 (ADC) 市場

  • 英國的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 英國的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 英國的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第17章 德國的抗體藥物複合體 (ADC) 市場

  • 德國的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 德國的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 德國的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第18章 法國的抗體藥物複合體 (ADC) 市場

  • 法國的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 法國的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 法國的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第19章 東歐的抗體藥物複合體 (ADC) 市場

  • 東歐的抗體藥物複合體 (ADC) 市場概要
  • 東歐的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 東歐的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 東歐的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第20章 俄羅斯的抗體藥物複合體 (ADC) 市場

  • 俄羅斯的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 俄羅斯的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 俄羅斯的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第21章 北美的抗體藥物複合體 (ADC) 市場

  • 北美的抗體藥物複合體 (ADC) 市場概要
  • 北美的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 北美的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 北美的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第22章 美國的抗體藥物複合體 (ADC) 市場

  • 美國的抗體藥物複合體 (ADC) 市場概要
  • 美國的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 美國的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 美國的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第23章 南美的抗體藥物複合體 (ADC) 市場

  • 南美的抗體藥物複合體 (ADC) 市場概要
  • 南美的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 南美的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 南美的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第24章 巴西的抗體藥物複合體 (ADC) 市場

  • 巴西的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 巴西的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 巴西的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第25章 中東的抗體藥物複合體 (ADC) 市場

  • 中東的抗體藥物複合體 (ADC) 市場概要
  • 中東的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 中東的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 中東的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第26章 非洲的抗體藥物複合體 (ADC) 市場

  • 非洲的抗體藥物複合體 (ADC) 市場概要
  • 非洲的抗體藥物複合體 (ADC) 市場:各類型,實際成果與預測 (金額)
  • 非洲的抗體藥物複合體 (ADC) 市場:各適應症,實際成果與預測 (金額)
  • 非洲的抗體藥物複合體 (ADC) 市場:各產品,實際成果與預測 (金額)

第27章 抗體藥物複合體 (ADC) 市場競爭情形和企業簡介

  • 抗體藥物複合體 (ADC) 市場競爭情形
  • 抗體藥物複合體 (ADC) 市場企業簡介
    • Bayer AG
    • Concortis Biotherapeutics
    • F. Hoffman-La Roche Ltd.
    • Immunomedics, Inc.
    • Oxford BioTherapeutics

第28章 抗體藥物複合體 (ADC)的開發平台分析

第29章 抗體藥物複合體 (ADC) 市場上主要的收購與合併

第30章 抗體藥物複合體 (ADC) 市場未來發展預測與潛在的分析

第31章 附錄

目錄
Product Code: h886

Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antibody drug conjugates market.

The report focuses on the antibody drug conjugates market which is experiencing strong growth. The report gives a guide to the antibody drug conjugates market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antibody drug conjugates? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antibody Drug Conjugates Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Linker; Drug/Toxin; Others

2) By Application: Blood Cancer; Breast Cancer; Ovarian Cancer; Lung Cancer; Brain Tumor; Others

3) By Product: Adcertis; Kadcyla; Others

4) By Technology: Immunogen Technology; Seattle Genetics Technology; Immunomedics Technology; Others

5) By End User: Hospital; Clinics; Others

Companies Mentioned: Bayer AG; Concortis Biotherapeutics; F. Hoffman-La Roche Ltd.; Immunomedics; Oxford BioTherapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antibody Drug Conjugates Market Characteristics

3. Antibody Drug Conjugates Market Trends And Strategies

4. Impact Of COVID-19 On Antibody Drug Conjugates

5. Antibody Drug Conjugates Market Size And Growth

  • 5.1. Global Antibody Drug Conjugates Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Antibody Drug Conjugates Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Antibody Drug Conjugates Market Segmentation

  • 6.1. Global Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal Antibodies
  • Linker
  • Drug/Toxin
  • Others
  • 6.2. Global Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Blood Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Brain Tumor
  • Others
  • 6.3. Global Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Adcertis
  • Kadcyla
  • Others
  • 6.4. Global Antibody Drug Conjugates Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Immunogen Technology
  • Seattle Genetics Technology
  • Immunomedics Technology
  • Others
  • 6.5. Global Antibody Drug Conjugates Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital
  • Clinics
  • Others

7. Antibody Drug Conjugates Market Regional And Country Analysis

  • 7.1. Global Antibody Drug Conjugates Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Antibody Drug Conjugates Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Antibody Drug Conjugates Market

  • 8.1. Asia-Pacific Antibody Drug Conjugates Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Antibody Drug Conjugates Market

  • 9.1. China Antibody Drug Conjugates Market Overview
  • 9.2. China Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Antibody Drug Conjugates Market

  • 10.1. India Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Antibody Drug Conjugates Market

  • 11.1. Japan Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Antibody Drug Conjugates Market

  • 12.1. Australia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Antibody Drug Conjugates Market

  • 13.1. Indonesia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Antibody Drug Conjugates Market

  • 14.1. South Korea Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Antibody Drug Conjugates Market

  • 15.1. Western Europe Antibody Drug Conjugates Market Overview
  • 15.2. Western Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Antibody Drug Conjugates Market

  • 16.1. UK Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Antibody Drug Conjugates Market

  • 17.1. Germany Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Antibody Drug Conjugates Market

  • 18.5. France Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Antibody Drug Conjugates Market

  • 19.1. Eastern Europe Antibody Drug Conjugates Market Overview
  • 19.2. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Antibody Drug Conjugates Market

  • 20.1. Russia Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Antibody Drug Conjugates Market

  • 21.1. North America Antibody Drug Conjugates Market Overview
  • 21.2. North America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Antibody Drug Conjugates Market

  • 22.1. USA Antibody Drug Conjugates Market Overview
  • 22.2. USA Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Antibody Drug Conjugates Market

  • 23.1. South America Antibody Drug Conjugates Market Overview
  • 23.2. South America Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Antibody Drug Conjugates Market

  • 24.1. Brazil Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Antibody Drug Conjugates Market

  • 25.1. Middle East Antibody Drug Conjugates Market Overview
  • 25.2. Middle East Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Antibody Drug Conjugates Market

  • 26.1. Africa Antibody Drug Conjugates Market Overview
  • 26.2. Africa Antibody Drug Conjugates Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Antibody Drug Conjugates Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Antibody Drug Conjugates Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Antibody Drug Conjugates Market Competitive Landscape And Company Profiles

  • 27.1. Antibody Drug Conjugates Market Competitive Landscape
  • 27.2. Antibody Drug Conjugates Market Company Profiles
    • 27.2.1. Bayer AG
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Concortis Biotherapeutics
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffman-La Roche Ltd.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Immunomedics, Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Oxford BioTherapeutics
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Antibody Drug Conjugates Pipeline Analysis

29. Key Mergers And Acquisitions In The Antibody Drug Conjugates Market

30. Antibody Drug Conjugates Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer